Pharmacogenomics of sickle cell disease: steps toward personalized medicine

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter: 3 X users
facebook: 2 Facebook pages

reddit: 1 Redditor

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Facebook Reddit Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications

Article in International Journal of Molecular Sciences (April 2024)

The dawn of a cure for sickle cell disease through CRISPR‐based treatment: A critical test of equity in public health genomics

Article in Annals of Human Genetics (March 2024)

Influence of Hemoglobin S Haplotypes on the Responses to Hydroxyurea Treatment in Children with Sickle Cell Disease in Abidjan, Côte d’Ivoire

Article in Open Journal of Genetics (March 2024)